Exploring perspectives on the benefits of a tuberculosis short-treatment regimen: a cross-sectional study on treatment experiences and perceptions

Exploring perspectives on the benefits of a tuberculosis short-treatment regimen: a cross-sectional study on treatment experiences and perceptions

Saved in:

Bibliographic Details
Main Authors:	Fernando Pereira da Silva, João Pedro Ramos, Pedro Barbosa, Mariana Vieira, Raquel Duarte
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Pneumologia e Tisiologia 2025-06-01
Series:	Jornal Brasileiro de Pneumologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132025000201300&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Perceptions and experiences of directly observed treatment in tuberculosis: insights from a mixed-methods cross-sectional study
by: Diana Amorim, et al.
Published: (2025-01-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

Use of Short Oral Regimens for Treatment of Drug Resistant Tuberculosis in a Patient with HIV Infection
by: S. Yu. Degtyareva, et al.
Published: (2023-03-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Recent advancements in tuberculosis (TB) treatment regimens
by: Shyamala Ravikoti, et al.
Published: (2025-02-01)

Evaluation of a modified short all oral treatment regimen for rifampicin-multidrug resistant tuberculosis in Dominican Republic
by: María Rodríguez, et al.
Published: (2025-02-01)

Safety of new tuberculosis treatment regimens and compliance with these regimens according to data from the Republic of Kazakhstan
by: Zh. T. Zhandauletova, et al.
Published: (2023-03-01)

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
by: Xubin Zheng, et al.
Published: (2023-12-01)

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.
by: William J Burman, et al.
Published: (2008-08-01)

Biotransformation enzymes for xenobiotics and personalization of treatment regimens for tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2016-04-01)

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
by: E. S. Ovsyankina, et al.
Published: (2024-12-01)

Contemporary approaches to the search for active drugs and chemotherapy regimens for tuberculosis treatment
by: T. K. Lugovkinа, et al.
Published: (2020-07-01)

Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens.
by: Dzintars Gotham, et al.
Published: (2025-01-01)

ADVERSE SIDE EFFECTS OF TUBERCULOSIS ETIOTROPIC TREATMENT REGIMENS CONTAINING THE NEW ANTI-TUBERCULOSIS DRUG OF SQ109
by: S. E. Borisov
Published: (2018-08-01)

A Leap Forward – All Oral Regimens Revolutionizing Multidrug-resistant Tuberculosis Treatment
by: Durga Balagopalan
Published: (2025-07-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01)

Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis)
by: A. I. Gayda, et al.
Published: (2024-05-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Efficacy and safety of a novel short course rifapentine and isoniazid regimen for the preventive treatment of tuberculosis in Chinese silicosis patients: a pilot study (SCRIPT-TB)
by: Qiao-Ling Ruan, et al.
Published: (2025-12-01)

Pretomanid: Clinical Trials and Prospects to Be Used in Treatment Regimens for Multiple and Extensive Drug Resistant Tuberculosis
by: A. V. Kukurika
Published: (2021-07-01)

Parameters of Complete Blood Count and Blood Chemistry during Treatment of Patients with MDR/XDR Pulmonary Tuberculosis with a Short-Course Regimen Containing Bedaquiline, Pretomanid, and Linezolid
by: R. Yu. Abdullaev, et al.
Published: (2023-08-01)

Evaluation of Safety of 9- and 6-Month Treatment Regimens in Patients with Rifampicin-Resistant Tuberculosis in the Republic of Belarus
by: N. V. Yatskevich, et al.
Published: (2024-03-01)

Assessment of effectiveness of the empiric treatment regimen in tuberculosis patients suspected with multiple drug resistance in the Russian Federation
by: Sergey A. Sterlikov, et al.
Published: (2018-11-01)

Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy
by: Yun Liang, et al.
Published: (2024-09-01)

Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review
by: Sipang Pangprasertkul, et al.
Published: (2025-03-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Clinical efficacy and computed tomography diagnostic value of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis
by: Saiduo Liu, et al.
Published: (2024-09-01)

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.
by: Gwenan M Knight, et al.
Published: (2015-01-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)

Treatment Outcomes for Drug-Resistant Tuberculosis Patients on Bedaquiline-Based Regimens in a Mostly Rural South Africa
by: Rukasha I, et al.
Published: (2025-04-01)

Treatment outcomes of regimens containing delamanid within therapy of multiple and extensive drug resistant tuberculosis in the Russian Federation
by: A. O. Maryandyshev, et al.
Published: (2019-12-01)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
by: Ntwali Placide Nsengiyumva, et al.
Published: (2022-06-01)

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment
by: Hélène E. Aschmann, et al.
Published: (2024-12-01)

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
by: Florence O Bada, et al.
Published: (2020-01-01)

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization.
by: Mohammad R Nikmaneshi, et al.
Published: (2023-06-01)

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis
by: L. V. Panova, et al.
Published: (2021-11-01)

Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023
by: Andrei Dadu
Published: (2025-07-01)

Successful Treatment of Severe Tuberculosis With Contezolid Add‐On Regimen in a Patient Complicated With Acute Thrombocytopenia: A Case Report
by: Liuqing Zhou, et al.
Published: (2024-12-01)

Gut microbiota modulation and health benefits of various fasting regimens
by: Sumel Ashique, et al.
Published: (2025-01-01)

Simulation of Conditions and Results of Implementation of Short-Course Treatment Regimes in Tuberculosis Patients
by: V. S. Burykhin, et al.
Published: (2023-12-01)